1. Home
  2. ZCMD vs CASI Comparison

ZCMD vs CASI Comparison

Compare ZCMD & CASI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ZCMD
  • CASI
  • Stock Information
  • Founded
  • ZCMD 2012
  • CASI 1991
  • Country
  • ZCMD China
  • CASI China
  • Employees
  • ZCMD N/A
  • CASI N/A
  • Industry
  • ZCMD Other Consumer Services
  • CASI Biotechnology: Pharmaceutical Preparations
  • Sector
  • ZCMD Real Estate
  • CASI Health Care
  • Exchange
  • ZCMD Nasdaq
  • CASI Nasdaq
  • Market Cap
  • ZCMD 30.3M
  • CASI 33.4M
  • IPO Year
  • ZCMD 2020
  • CASI 1996
  • Fundamental
  • Price
  • ZCMD $1.24
  • CASI $2.10
  • Analyst Decision
  • ZCMD
  • CASI Strong Buy
  • Analyst Count
  • ZCMD 0
  • CASI 1
  • Target Price
  • ZCMD N/A
  • CASI $6.00
  • AVG Volume (30 Days)
  • ZCMD 3.5K
  • CASI 8.5K
  • Earning Date
  • ZCMD 01-01-0001
  • CASI 03-31-2025
  • Dividend Yield
  • ZCMD N/A
  • CASI N/A
  • EPS Growth
  • ZCMD N/A
  • CASI N/A
  • EPS
  • ZCMD N/A
  • CASI N/A
  • Revenue
  • ZCMD $17,406,104.00
  • CASI $28,537,000.00
  • Revenue This Year
  • ZCMD N/A
  • CASI N/A
  • Revenue Next Year
  • ZCMD N/A
  • CASI $134.79
  • P/E Ratio
  • ZCMD N/A
  • CASI N/A
  • Revenue Growth
  • ZCMD 1.01
  • CASI N/A
  • 52 Week Low
  • ZCMD $1.00
  • CASI $2.04
  • 52 Week High
  • ZCMD $2.97
  • CASI $7.67
  • Technical
  • Relative Strength Index (RSI)
  • ZCMD 45.49
  • CASI 42.35
  • Support Level
  • ZCMD $1.20
  • CASI $2.10
  • Resistance Level
  • ZCMD $1.34
  • CASI $2.52
  • Average True Range (ATR)
  • ZCMD 0.07
  • CASI 0.21
  • MACD
  • ZCMD 0.01
  • CASI 0.00
  • Stochastic Oscillator
  • ZCMD 22.22
  • CASI 12.50

About ZCMD Zhongchao Inc.

ZHONGCHAO Inc is a Cayman Islands-based provider of healthcare information, education, and training services. It provides services to healthcare professionals and the public in China. It offers online and onsite health information services, healthcare education programs, and healthcare training products, consisting of clinical practice training, open classes of popular medical topics, interactive case studies, academic conferences and workshops, continuing education courses, and articles and short videos with educational healthcare content.

About CASI CASI Pharmaceuticals Inc.

CASI Pharmaceuticals Inc is a biopharmaceutical company that focuses on commercializing therapeutics and pharmaceutical products. The products include injections for patients who are suffering from leukemias and lymphomas. The EVOMELA injection is used as a conditioning treatment before autologous stem cell transplant for patients with multiple myeloma. The company products include CID-103, CNCT19, EVOMELA, MARQIBO, ZEVALIN, ENMD-2076 and others. The majority of the revenue is generated from the product sales of EVOMELA.

Share on Social Networks: